The global probiotics and prebiotics market size valued USD 60.4 billion in 2020 and expected to reach USD 90.3 billion by 2027, at a CAGR of 8.6% during the forecast period 2021-2027. Probiotics are live micro-organisms, which are administered in adequate amounts, confer health benefits on a host. They positively alter the body’s bacterial composition to encourage overall wellness. Some strains provide such specific benefits as improved intestinal function and increased immune response. Prebiotics are food for probiotics and selectively fermented by the beneficial bacteria. When the two are found together, they work in synergy, with the process described. Interminable efforts are being made by the key players and healthcare organizations in order to enhance the consumer base of the probiotics and prebiotics globally. Product launches are the key strategy adopted by the market players to enhance the growth along with acquisitions, mergers, collaborations etc. Obesity is increasing in humans owing to the high sugar levels, calories and fat intake which may lead to the increase in the risk of hypertension and diabetes. Consumption of prebiotics enables probiotics growth which helps the human body to fight against the chronic diseases. For instance, Beneo-Orafti SA involved in production & also sales of oligofructose and inulin food ingredients which are derived from the chicory and company offers food ingredients, dietary supplements, functional foods and confectionery for food and beverage industries. Beneo-Orafti SA will operate as the subsidiary of RaffinerieTirlemontoise SA and has sales network in North America, Europe, Asia Pacific and Latin America.